The molecular pathogenesis of chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

The molecular pathogenesis of chronic lymphocytic leukaemia

Published:2016-02-25 Issue:3 Volume:16 Page:145-162
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Fabbri Giulia,Dalla-Favera Riccardo

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/nrc.2016.8.pdf

Reference217 articles.

1. Howlader, N. et al. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute Surveillance, Epidemiology and End Results Program [online] (2013).

2. Yang, S. M., Li, J. Y., Gale, R. P. & Huang, X. J. The mystery of chronic lymphocytic leukemia (CLL): why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology? Blood Rev. 29, 205–213 (2015).

3. Goldin, L. R., Pfeiffer, R. M., Li, X. & Hemminki, K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104, 1850–1854 (2004).

4. Hallek, M. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111, 5446–5456 (2008).

5. Hallek, M. Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am. J. Hematol. 90, 446–460 (2015).

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-1 receptor antagonism reveals a yin-yang relationship between NFκB and interferon signaling in chronic lymphocytic leukemia;Proceedings of the National Academy of Sciences;2024-08-09

2. Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT);Leukemia Research;2024-08

3. Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation;Cell Death & Disease;2024-07-03

4. The malignant transformation potential of the oncogene STYK1/NOK at early lymphocyte development in transgenic mice;Biochemistry and Biophysics Reports;2024-07

5. Molecular Pathology of Mature Lymphoid Malignancies;Clinics in Laboratory Medicine;2024-06